Topic: Remdesivir

The FBI and federal cybersecurity agents warned that hackers linked to the Chinese and Iranian governments were targeting U.S. universities and pharmaceutical companies to steal COVID-19 research. Assistant Attorney General John Demers stated that China is desperate to be the first to develop a vaccine for geopolitical prestige. Tensions escalated as President Trump suggested reporters "ask China" about the global death toll during a press briefing.

During an NPR segment, Dr. Arturo Casadevall of Johns Hopkins discussed COVID-19 treatments like Remdesivir and monoclonal antibodies while completely avoiding any mention of Ivermectin. The hosts criticize the expert for omitting a widely discussed alternative treatment. They suggest that the media is intentionally suppressing information that could help patients recover outside of hospitals.

Dr. Deborah Birx appeared on ABC to discuss the predictable nature of COVID-19 summer waves and the need for seasonal boosters. Birx suggests that mRNA technology should be used to tailor vaccines for specific variants like BA.2.86 by January. The hosts critique her claims regarding the severity of COVID-19 compared to the flu and her dismissal of monoclonal antibodies in favor of antivirals like Remdesivir.

Dr. Bryan Ardis testified that Anthony Fauci knowingly promoted Remdesivir despite its high mortality rate in African Ebola trials. Ardis claims the drug causes multiple organ failure, which is often misattributed to COVID-19. He expressed concern that the drug is now being authorized for use in children.

The FDA's Coronavirus Treatment Acceleration Program reported that 19 therapies, including Remdesivir, were in active testing. In Russia, Ural Cossacks began unofficial patrols in Yekaterinburg, handing out masks and recommending traditional remedies like honey, garlic, and holy water. The Cossacks framed their involvement as a patriotic duty to support the state during the crisis.

States like Florida and Texas began phased reopening plans for beaches and retail stores with occupancy limits. Gilead's stock rose following positive reports on Remdesivir's effectiveness in Chicago trials. Additionally, health officials confirmed the first US cases of pet cats testing positive for coronavirus in New York, though there was no evidence of animal-to-human transmission.

Senator Ron Johnson hosted a panel featuring medical experts and whistleblowers to discuss the federal pandemic response. Registered nurse Nicole Sirotek testified about gross negligence in New York hospitals, alleging that patients were dying from medical mismanagement rather than COVID-19. The panel highlighted concerns regarding Remdesivir, citing studies that suggest it increases the risk of renal failure and death, while noting federal financial incentives for hospitals to use the drug.

The hosts sign off by promoting "Planet Rage" with Larry and Darren. The episode ends with a montage of clips featuring the "Ozymandias" poem, critiques of Remdesivir death rates, and the full "Drone Again Naturally" parody song. They remind listeners to visit Dvorak.org/NA and wish everyone a Happy Veterans Day and Remembrance Day.

Attorney Thomas Renz is pursuing legal action against hospitals and doctors for wrongful death and intentional torts related to COVID-19 treatment protocols. Renz cites whistleblower data alleging a 25.7% death rate associated with Remdesivir, along with high rates of kidney failure and sepsis. The legal argument focuses on "battery," claiming hospitals administered the drug against patient wishes and followed protocols that prioritized clearing beds over patient survival.

The acting Chief Medical Officer of Victoria, Australia, stated that ivermectin has no role in COVID-19 treatment. This is contrasted with the use of Remdesivir, which is alleged to cause kidney failure in a significant percentage of patients.

The official US response to COVID-19 is criticized for focusing solely on masks and vaccines while offering little to the sick. A Harvard study is cited showing a 38% mortality rate for ICU patients. Telemedicine networks like MyFreeDoctor.com, founded by Ben Marble, are highlighted as the "real heroes" for providing early treatment protocols to outpatients.

The World Health Organization (WHO) has officially removed Remdesivir from its list of recommended COVID-19 treatments. The drug, which was heavily promoted by mainstream media and health agencies as a primary antiviral against the virus, has faced ongoing questions regarding its actual efficacy and safety profile.

Reports from producers in India indicate that local officials in several states stopped distributing Ivermectin and Z-Pak kits shortly before the April spike in cases. While hospitals report a shortage of "COVID beds," it is noted that these are often a small percentage of total hospital capacity. The political landscape is dominated by calls for Prime Minister Modi's resignation, mirroring tactics used against other populist leaders like Donald Trump and Jair Bolsonaro.

Reports from multi-hospital systems suggest an increase in mortality rates following the approval and use of Remdesivir. Additionally, a medical analysis using Bayes' Theorem indicates that PCR tests may have a false-positive rate as high as 90% in certain scenarios. This suggests that a positive test does not necessarily equate to an infectious individual.

NBC Nightly News reported on the critical 48-hour window for President Trump's health and the conflicting messages from his medical team. The President is receiving experimental treatments including Remdesivir and a Regeneron monoclonal antibody cocktail. Media reports focused heavily on whether the President required supplemental oxygen during his stay at Walter Reed, despite the White House's attempts to project an image of strength.

French doctor Didier Raoult, an early proponent of hydroxychloroquine, has alleged receiving death threats from individuals linked to Gilead Sciences. The conflict centers on the competition between the inexpensive hydroxychloroquine treatment and Gilead's high-priced Remdesivir. The hosts discuss the cutthroat nature of the pharmaceutical industry during the pandemic.

A lab technician's report suggests anomalies in the primers used for COVID-19 PCR tests, raising questions about testing accuracy. Additionally, the antiviral drug Remdesivir is characterized as ineffective in certain clinical settings, leading some labs to cease testing. Despite rising case numbers, San Diego has begun loosening restrictions on salons and indoor dining, coinciding with the shift in pharmaceutical narratives.

Executive producers contributed significant financial support, including a $500 donation from a Manhattan resident struggling with lockdowns. A physician from Virginia also shared medical insights from JAMA regarding the lack of efficacy for Remdesivir and the successful use of hydroxychloroquine in India.

Dr. Simone Gold explained that the FDA cannot grant Emergency Use Authorization (EUA) for new vaccines if an existing, approved medication is effective against the target disease. She alleged that the suppression of hydroxychloroquine serves the financial interests of companies like Gilead, which produces the more expensive Remdesivir. This regulatory hurdle provides a potential motive for the intense public campaign against generic therapeutics.

Research into COVID-19 therapeutics suggests that the active metabolite in Remdesivir, GS-441524, is also known as a feline antiviral. Additionally, studies indicate that melatonin may inhibit the cytokine storm induced by COVID-19. The hosts discuss the common household use of melatonin for sleep and jet lag.